{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:33Z","timestamp":1789616193831,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In this systematic review and meta-analysis, we aimed to evaluate the anti-osteoporotic efficacy of puerarin in rodent models of osteoporosis (OP) and to explore the impact of the dosage, treatment duration, and intervention method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of electronic databases (e.g., PubMed, Embase, Web of Science, CNKI, and Wanfang) was conducted through August 2025. Randomized controlled trials investigating the effects of puerarin monotherapy on osteoporotic rats were included. The primary outcome measured was bone mineral density (BMD), and the secondary outcomes included bone histomorphometric parameters (BV\/TV, Tb.Th, Tb.N, and Tb.Sp) and bone turnover markers (e.g., PINP, BALP, CTX, TRACP, and osteocalcin). Data were pooled using a random-effects model, and subgroup analyses were performed based on the puerarin dose, treatment duration, and intervention method. The study quality was assessed using the SYRCLE risk-of-bias tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-eight studies involving 570 animals were included. The meta-analysis demonstrated that puerarin significantly increased femoral BMD (SMD = 2.95, 95% CI: 2.32 to 3.58, and p &amp;lt; 0.00001) and improved the bone microarchitecture by increasing BV\/TV, Tb.Th, and Tb.N, and decreasing Tb.Sp. Subgroup analysis revealed that the most pronounced BMD improvement occurred at doses \u226550\u00a0mg\/kg\/day administered for \u22658\u00a0weeks. Puerarin significantly suppressed bone resorption markers, CTX and TRACP, and elevated serum levels of osteocalcin, calcium, and phosphorus. However, its effects on bone formation markers, PINP and BALP, were not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Puerarin exhibits significant therapeutic potential for OP in rat models by increasing BMD, improving bone quality, and rebalancing bone metabolism in favor of formation, primarily through the inhibition of resorption. The optimal effect appears to be dose- and duration-dependent. Although these preclinical findings are promising, the clinical translation of puerarin requires validation through larger-scale, high-quality animal studies and subsequent clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1712682","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:37:27Z","timestamp":1767595047000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The anti-osteoporotic effect of puerarin on the femoral bone in rat models of osteoporosis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhaoxi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1038\/s41598-017-07014-0","article-title":"Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation","volume":"7","author":"Alippe","year":"2017","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2478\/jomb-2019-0002","article-title":"Correlation of Fgf23 and balp with bone mineral density in hemodialysis patients","volume":"38","author":"Bouksila","year":"2019","journal-title":"J. Med. Biochem."},{"key":"B4","first-page":"73","article-title":"Effect of puerarin combined with alendronate on oxidative stress, inflammation reaction, and bone metabolism in postmenopausal osteoporotic rats","volume":"27","author":"Chen","year":"2021","journal-title":"Chin. J. Osteoporos."},{"key":"B5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjog.2021.11.017","article-title":"Association between P1NP and bone strength in postmenopausal women treated with teriparatide","volume":"61","author":"Chen","year":"2022","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"B8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40266-018-0525-7","article-title":"Denosumab: a review in postmenopausal osteoporosis","volume":"35","author":"Deeks","year":"2018","journal-title":"Drugs Aging"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3969\/j.issn.1005-9202.2021.02.034","article-title":"Comparison of effects of camellia seed and puerarin on osteoporosis in ovariectomized rats","volume":"41","author":"Fang","year":"2021","journal-title":"Chin. J. Gerontology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40279-013-0100-7","article-title":"Bone quality: the determinants of bone strength and fragility","volume":"44","author":"Fonseca","year":"2014","journal-title":"Sports Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00198-022-06311-3","article-title":"The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis","volume":"33","author":"Gossiel","year":"2022","journal-title":"Osteoporos. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"108570","DOI":"10.1016\/j.biopha.2019.01.031","article-title":"Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1\/HDAC3 signaling","volume":"115","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B14","first-page":"499","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption","volume":"52","author":"Halleen","year":"2006","journal-title":"Clin. Lab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23956","DOI":"10.1038\/s41598-021-03214-x","article-title":"Common osteoporosis drug associated with increased rates of depression and anxiety","volume":"11","author":"Keshishi","year":"2021","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clin. Biochem."},{"key":"B19","first-page":"74","article-title":"Effect of puerarin on the bone metabolism in vitro","volume":"35","author":"Li","year":"2003","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"key":"B20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/13880209.2015.1017885","article-title":"Anti-osteoporotic activity of puerarin 6-O-xyloside on ovariectomized mice and its potential mechanism","volume":"54","author":"Li","year":"2016","journal-title":"Pharm. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3969\/j.issn.1674-2591.2019.01.007","article-title":"Effects of puerarin on prevention of disuse osteoporosis in hindlimb suspension rats","volume":"12","author":"Li","year":"2019","journal-title":"Chin. J. Osteoporos. Bone Mineral Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"110923","DOI":"10.1016\/j.biopha.2020.110923","article-title":"Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"154198","DOI":"10.1016\/j.phymed.2022.154198","article-title":"Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics","volume":"102","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00198-016-3534-6","article-title":"Teriparatide for osteoporosis: importance of the full course","volume":"27","author":"Lindsay","year":"2016","journal-title":"Osteoporos. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.12174\/j.issn.2096-9600.2023.07.06","article-title":"Influence of puerarin on bone metabolic equilibrium in ovariectomized rats","volume":"36","author":"Lyu","year":"2023","journal-title":"West. J. Traditional Chin. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.13699\/j.cnki.1001-6821.2019.23.034","article-title":"Effect of puerarin injection combined with estradiol injection on healing of osteoporotic fracture in rats","volume":"35","author":"Niu","year":"2019","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jot.2022.01.003","article-title":"Puerarin specifically disrupts osteoclast activation via blocking integrin-\u03b23 Pyk2\/Src\/Cbl signaling pathway","volume":"33","author":"Qiu","year":"2022","journal-title":"J. Orthop. Transl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11972","DOI":"10.1111\/jcmm.15821","article-title":"Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-\u03baB signaling pathway","volume":"24","author":"Tang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.phymed.2012.07.010","article-title":"Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica","volume":"19","author":"Tiyasatkulkovit","year":"2012","journal-title":"Phytomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.phymed.2014.06.019","article-title":"Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts","volume":"21","author":"Tiyasatkulkovit","year":"2014","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.16766\/j.cnki.issn.1674-4152.000967","article-title":"Experimental study on treatment of osteoporosis with puerarin and zinc in ovariectomized rats","volume":"17","author":"Wang","year":"2019","journal-title":"Chin. J. General Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/10286020.2012.702757","article-title":"Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt\/\u03b2-catenin pathways","volume":"14","author":"Wang","year":"2012","journal-title":"J. Asian Nat. Prod. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.13699\/j.cnki.1001-6821.2020.14.039","article-title":"Effect of puerarin combined with estradiol on the healing of osteoporotic fracture in rats","volume":"36","author":"Wang","year":"2020","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2121106","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.xphs.2024.04.005","article-title":"Preparation of Puerarin long circulating liposomes and its effect on osteoporosis in castrated rats","volume":"113","author":"Wang","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3969\/j.issn.1003-0034.2018.07.010","article-title":"Resveratrol and puerarin on peak bone mass in young rats","volume":"31","author":"Xi","year":"2018","journal-title":"China J. Orthop. Traumatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.18632\/aging.103976","article-title":"Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6\/ROS-dependent MAPK\/NF-\u03baB signaling pathways","volume":"12","author":"Xiao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.12056\/j.issn.1006-2785.2021.43.5.2020-2134","article-title":"Effict of puerarin on bone loss in ovariectomized mice and its effect on RANKL\/RANK\/OPG signaling pathway","volume":"43","author":"Xu","year":"2021","journal-title":"Zhejiang Med. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.3969\/j.issn.1005-9202.2023.13.041","article-title":"The role of puerarin in ovariectomized osteoporotic rats based on the PPAR-\u03b3\/Axin2\/Wnt signaling pathway","volume":"43","author":"Yang","year":"2023","journal-title":"Chin. J. Gerontology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/1566524018666171219101142","article-title":"Puerarin stimulates osteogenic differentiation and bone formation through the ERK1\/2 and p38-MAPK signaling pathways","volume":"17","author":"Yang","year":"2018","journal-title":"Curr. Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3969\/j.issn.1006-7108.2021.03.020","article-title":"Effects of puerarin on oxidative stress response,bone metabolism,and bone mineral density in osteoporotic rats","volume":"27","author":"Yang","year":"2021","journal-title":"Chin. J. Osteoporos."},{"key":"B43","first-page":"213","article-title":"Therapeutic effect and mechanism of puerarin combined with estrogen in PMOP rats","volume":"42","author":"Yu","year":"2019","journal-title":"Heilongjiang Med. Pharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s1875-5364(16)30026-7","article-title":"Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro","volume":"14","author":"Yuan","year":"2016","journal-title":"Chin. J. Nat. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3969\/j.issn.1006-7108.2021.01.016","article-title":"Effect of puerarin on bone metabolism,bone mineral density,and bone biomechanics in postmenopausal osteoporosis rats","volume":"27","author":"Yue","year":"2021","journal-title":"Chin. J. Osteoporos."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.3969\/j.issn.1002-7386.2018.23.010","article-title":"Effects of puerarin on osteoporosis and PI3K\/AKT signaling pathway in ovariectomized female rats","volume":"40","author":"Zeng","year":"2018","journal-title":"Hebei Med. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.13898\/j.cnki.issn.1000-2200.2019.11.002","article-title":"Effect of puerarin on the bone tissue and PI3K\/Akt signal transduction pathway in rats with femoral head osteonecrosis induced by hormone","volume":"44","author":"Zeng","year":"2019","journal-title":"J. Bengbu Med. Univ."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1248\/bpb.b16-00522","article-title":"Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation","volume":"39","author":"Zhang","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"B49","first-page":"41","article-title":"Mechanism of puerarin promoting fracture healing and bone formation in rats with postmenopausal osteoporosis","volume":"42","author":"Zhang","year":"2024","journal-title":"J. Sichuan Traditional Chin."},{"key":"B50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.16833\/j.cnki.jbmc.2025.01.005","article-title":"Mechanism of puerarin in the treatment of PMOP rats based on JAK2\/STAT3 signaling pathway","volume":"41","author":"Zhao","year":"2024","journal-title":"J. Baotou Med. Coll."},{"key":"B51","first-page":"1","article-title":"Exploring the mechanism of action of puerarin on osteoporotic rats based on miRNA-21-5p\/TGF-\u03b21\/Smads signaling pathway","author":"Zhou","year":"2025","journal-title":"Chin. Pharm. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.26355\/eurrev_201906_18194","article-title":"Study on diagnostic value of P1NP and \u03b2-CTX in bone metastasis of patients with breast cancer and the correlation between them","volume":"23","author":"Zuo","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1712682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:37:41Z","timestamp":1767595061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1712682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":52,"alternative-id":["10.3389\/fphar.2025.1712682"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1712682","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1712682"}}